Clinical Trials
14
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
High Definition Medicine for Solid Tumors Oncology
- Conditions
- Metastatic Solid TumorAdvanced Cancer
- First Posted Date
- 2024-09-11
- Last Posted Date
- 2024-09-19
- Target Recruit Count
- 300
- Registration Number
- NCT06590506
- Locations
- 🇪🇸
Hospital Universitario A Coruña, La Coruña, A Coruña/ Galicia, Spain
🇪🇸Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain
🇪🇸Hospital Son Espases, Palma De Mallorca, Mallorca / Baleares, Spain
Prospective Multicentre Cohort Study PROREPAIR-B (mCRPC)
- Conditions
- Prostate Cancer
- First Posted Date
- 2017-03-09
- Last Posted Date
- 2019-02-04
- Target Recruit Count
- 408
- Registration Number
- NCT03075735
SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone
- Conditions
- Prostate Cancer
- Interventions
- Drug: Steroids switch
- First Posted Date
- 2016-10-10
- Last Posted Date
- 2017-01-27
- Target Recruit Count
- 26
- Registration Number
- NCT02928432
- Locations
- 🇪🇸
Spanish National Cancer Research Centre (CNIO), Madrid, Spain
PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223.
- Conditions
- Advanced Prostate CancerRadium 223Castration Resistant
- Interventions
- Drug: Radium 223 55mBq/Kg every 4 weeks intravenously
- First Posted Date
- 2016-10-06
- Last Posted Date
- 2020-01-27
- Target Recruit Count
- 161
- Registration Number
- NCT02925702
- Locations
- 🇪🇸
Hospital Arquitecto Marcide, Ferrol, A Coruña, Spain
🇪🇸Hospital Universitario de Santiago, Santiago de Compostela, A Coruña, Spain
🇪🇸Hospital Universitario de Elche, Elche, Alicante, Spain
PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide.
- Conditions
- Castration ResistantAdvanced Prostate CancerEnzalutamide
- First Posted Date
- 2016-10-04
- Last Posted Date
- 2020-01-27
- Target Recruit Count
- 187
- Registration Number
- NCT02922218
- Locations
- 🇪🇸
Hospital Arquitecto Marcide, Ferrol, A Coruña, Spain
🇪🇸Hospital Universitario de Santiago, Santiago de Compostela, A Coruña, Spain
🇪🇸ICO L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain
- Prev
- 1
- 2
- 3
- Next